Skip to main content
. Author manuscript; available in PMC: 2016 Dec 28.
Published in final edited form as: Inflamm Bowel Dis. 2015 Aug;21(8):1769–1775. doi: 10.1097/MIB.0000000000000427

Figure 1. Biomarker performance.

Figure 1

Figure 1

Receiver operator curves of the various leukocyte subtypes and ratios in UC active compared to non-IBD controls (A) and UC active compared to C diff. controls (B).